Sort
51,570 grants matching “autoimmune disease”
Immune Tolerance Network
$4,500,000Gerald T Nepom · Benaroya Research Inst At Virginia Mason · UM1 · FY2021 · AI
Pathogenesis And Treatment Of Aplastic Anemia
$4,499,584Neal S Young · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Immune Tolerance Network: Type 1 diabetes
$4,435,333Jeffrey A Bluestone · University Of California, San Francisco · N01 · FY2009 · AI
Multimodal MRI in Multiple Sclerosis
$4,417,917Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
The VITamin D and OmegA-3 TriaL (VITAL)
$4,413,440Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2017 · CA
Regulation of B cell Responses in SLE and Other Autoimmune Diseases
$4,394,852Ignacio E. Sanz · Emory University · U19 · FY2025 · AI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases
$4,394,852Ignacio E. Sanz · Emory University · U19 · FY2024 · AI
Translational Immunology research: a support for clinical immunological research
$4,389,189Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2012 · AR
Administrative Core
$4,377,647Ignacio E. Sanz · Emory University · U19 · FY2019 · AI
The VITamin D and OmegA-3 TriaL (VITAL)
$4,377,141Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2016 · CA
Stat transcription factors in immunoregulation and autoimmune disease
$4,374,543John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Oklahoma Shared Clinical and Translational Resources
$4,357,718Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2025 · GM
The VITamin D and OmegA-3 TriaL (VITAL)
$4,335,161Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2015 · CA
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$4,334,483Rachel R. Caspi · National Eye Institute · ZIA · FY2025 · EY
Autoimmune Diseases Group
$4,327,683Lynette Keyes-Elstein · Rho Federal Systems Division, Inc. · UM2 · FY2018 · AI
Pathogenic Mechanisms in Spondyloarthritis
$4,318,760Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
$4,313,916Christina Millin · Rho Federal Systems Division, Inc. · N01 · FY2022 · AI
Oklahoma Shared Clinical and Translational Resources
$4,299,999Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2023 · GM
Coordinating Center for Organ Transplant Clinical Trials (U01)
$4,289,607David N. Ikle · Rho Federal Systems Division, Inc. · U01 · FY2014 · AI
Studies of Inherited Causes of Fungal Susceptability
$4,286,269Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure
$4,250,620Johnnye L Lewis · University Of New Mexico Health Scis Ctr · UH3 · FY2019 · OD
Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure
$4,249,553Debra Mackenzie · University Of New Mexico Health Scis Ctr · UH3 · FY2021 · OD
Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure
$4,249,552Debra Mackenzie · University Of New Mexico Health Scis Ctr · UH3 · FY2022 · OD
Asthma and Allergic Diseases Group
$4,246,651Samuel Arbes · Rho Federal Systems Division, Inc. · UM2 · FY2020 · AI
Discretionary Fund
$4,245,850Eugene W. St Clair · Duke University · U19 · FY2009 · AI